FDA Perspectives on the Regulation of Neuromodulation Devices.
Neuromodulation
; 23(1): 3-9, 2020 Jan.
Article
em En
| MEDLINE
| ID: mdl-31965667
ABSTRACT
The United States Food and Drug Administration (FDA) ensures that patients in the United States have access to safe and effective medical devices. The division of neurological and physical medicine devices reviews medical technologies that interface with the nervous system, including many neuromodulation devices. This article focuses on neuromodulation devices and addresses how to navigate the FDA's regulatory landscape to successfully bring devices to patients.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Estimulação Elétrica Nervosa Transcutânea
/
Aprovação de Equipamentos
/
Neuroestimuladores Implantáveis
Tipo de estudo:
Prognostic_studies
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Neuromodulation
Ano de publicação:
2020
Tipo de documento:
Article